Table 6.
Results of treatment-group patients on secondary outcome measures at pre- and posttest
Patient number | Stroop CWT processing speed | Stroop CWT inhibition | Adapted MSET | SIB distressa | SCL-90-R anxietya | SCL-90-R depressiona | Quality of lifea | Self-efficacya | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pre | Post | Pre | Post | Pre | Post | Pre | Post | Pre | Post | Pre | Post | Pre | Post | Pre | Post | |
1 | 53.5 | 48.5 | 1.38 | 1.42 | 20.67 | 6.67 | 121 | 179 | 19 | 25 | 41b | 43 | 12 | 10 | 36 | 32 |
2 | 62.5 | 61.5 | 1.79 | 1.61 | 12.67 | 20.00 | 87 | 84 | 13 | 10 | 24 | 18 | 15 | 17 | 34 | 43 |
3 | 46.5 | 58.0 | 2.00 | 1.45 | 23.80 | 14.33 | – | – | 20 | – | 53b | – | 7 | – | 29 | – |
4 | 69.0 | 61.0 | 1.78 | 1.67 | 21.75 | 12.17 | 107 | 145 | 14 | 15 | 19 | 21 | 12 | 14 | 38 | 34 |
5 | 47.5 | 45.0 | 1.62 | 1.67 | 7.33 | 2.33 | 109 | 94 | 17 | 13 | 32 | 29 | 13 | 12 | 42 | 44 |
6 | 57.5 | 54.5 | 1.72 | 1.61 | 16.33 | 6.00 | 133 | 123 | 18 | 20 | 24 | 24 | 14 | 15 | 36 | 38 |
Median | 55.50 | 56.25 | 1.75 | 1.61 | 18.50 | 9.42 | 109.00 | 123.00 | 17.00 | 15.00 | 24.00 | 24.00 | 13.00 | 14.00 | 36.00 | 38.00 |
Interquartile range | 16.88 | 13.50 | 0.28 | 0.23 | 10.93 | 10.67 | 30.00 | 73.00 | 5.00 | 11.00 | 15.00 | 16.50 | 2.50 | 5.00 | 5.00 | 10.50 |
Td | 6.00 | 3.00 | 2.00 | 6.00 | 7.00 | 3.00 | 5.50 | 7.00 | ||||||||
z | −0.94 | −1.57 | −1.78 | −0.41 | −0.14 | −0.74 | −0.55 | −0.14 | ||||||||
P-value | 0.44 | 0.16 | 0.09 | 0.81 | 1.00 | 0.63 | 0.81 | 1.00 | ||||||||
rc | −0.27 | −0.45 | −0.51 | −0.13 | −0.04 | −0.23 | −0.17 | −0.04 |
Note:
Median and interquartile range calculated for five participants;
low/high performance at pretest;
effect size;
Test statistic of Wilcoxon signed-rank test reflecting the smallest sum of ranks.
Abbreviations: CWT, color-word test; MSET, modified six-elements test; SCL-90-R, Symptom Checklist 90, revised; SIB, Scale for Interpersonal Behavior.